Since starting operations in North Carolina 30 years ago, Biogen has spent approximately $10 billion to bolster its manufacturing presence in the Tar Heel state. But that’s not enough for the Massachusetts-based biotech, which says it will spend $2 billion more over the next three years, adding factories and upgrades at its two sprawling campuses in the Research Triangle Park (RTP).
